-

Kirby McInerney LLP Reminds The Trade Desk, Inc. Investors of Class Action Filing and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors who purchased The Trade Desk, Inc. (“TTD” or the “Company”) (NASDAQ:TTD) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to the securities fraud class action lawsuit against the Company.

[CONTACT FORM]

The lawsuit was filed on behalf of investors who acquired TTD securities from May 9, 2024, through February 12, 2025 (“the Class Period”). Investors have until April 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The complaint alleges that defendants, throughout the Class Period, made materially misleading statements that failed to disclose that: (1) Trade Desk was experiencing significant, ongoing, self-inflicted execution challenges rolling out Kokai, including transitioning clients to Kokai from the Company’s older platform Solimar; (2) such execution challenges meaningfully delayed the rollout of Kokai; and (3) Trade Desk’s inability to effectively execute the rollout of Kokai negatively impacted the Company’s business and operations, particularly revenue growth.

[LEARN MORE ABOUT THE CLASS ACTION]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

Kirby McInerney LLP

NASDAQ:TTD

Release Versions
$Cashtags

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com

More News From Kirby McInerney LLP

PPTA INVESTORS: Kirby McInerney LLP Reminds Perpetua Resources Corp. Investors of Important Deadline and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of Idaho on behalf of those who acquired Perpetua Resources Corp. (“Perpetua” or the “Company”) (NASDAQ:PPTA) securities during the period from April 17, 2024, through February 13, 2025 (“the Class Period”). Investors have until May 20, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit. [LEARN MORE ABOU...

Kirby McInerney LLP Urges Investors in Maravai Lifesciences Holdings, Inc. to Inquire About Their Rights in Class Action Lawsuit

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of California on behalf of those who acquired Maravai Lifesciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ:MRVI) securities during the period from August 7, 2024, through February 24, 2025 (“the Class Period”). Investors have until May 5, 2025, to apply to the Court to be appointed as lead plaintiff in the la...

Kirby McInerney LLP Urges Investors in e.l.f. Beauty, Inc. (ELF) to Inquire About Their Rights in Class Action Lawsuit

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired e.l.f. Beauty, Inc. (“ELF” or the “Company”) (NYSE:ELF) securities during the period from May 25, 2023, through February 6, 2025 (“the Class Period”). Investors have until May 5, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit. [LEARN MORE ABOUT T...
Back to Newsroom